Results 121 to 130 of about 16,115 (161)

Anti-ANGPTL3 antibody and IL-22 fusion protein mitigate nephrotic syndrome via mitochondrial protection, anti-apoptosis, and autophagy suppression. [PDF]

Antib Ther
Ma Q, Shao L, Jing G, Liu F, Zhou K, Wen F, He H, Ju D, Xu H.   +8 more
europepmc   +1 more source

Emerging therapeutic pipelines on kidney fibrosis: challenges in translational research. [PDF]

J Transl Med
Granata S, Barberio L, D'Agostino R, Sorace F, Leone F, Pellegrino D, Stallone G, Provenzano M, Zaza G.   +8 more
europepmc   +1 more source

Breaking tolerance in the glomerulus: complement as a driver and therapeutic target in IgA nephropathy. [PDF]

Front Med (Lausanne)
Lu CL, Yang CC, Wu CC, Lu KC.
europepmc   +1 more source

Pathology-Anchored Biomarker Research Progress for the Early Diagnosis of Diabetic Kidney Disease: From Pathological Association to Early Validation. [PDF]

Biomedicines
Li Q, Yang M, Luo Y, Zhang N.
europepmc   +1 more source

Natural product therapy in diabetic kidney disease: emerging multiomics-mediated signalling pathway and molecular target. [PDF]

Chin Med
Wang KE, Yu QQ, Wang WF, Wang YN, Yang J, Miao H, Liu LM, Zhao YY.   +7 more
europepmc   +1 more source

Long-Term Empagliflozin Treatment (50 Days) Attenuates Protease Activity, Migration, and Stemness-Associated Phenotypes in BFTC-909 Renal Pelvis Transitional Cell Carcinoma Cells. [PDF]

J Cancer
Lee YH, Chen PN, Hsieh YH, Chu YC, Chen LJ, Lin CY, Yang SF, Chang HR.   +7 more
europepmc   +1 more source

Targeting ANGPTL3 and IL-33/ST2 Ameliorates Diabetic Kidney Disease by Reducing Lipotoxicity, Alleviating Inflammation and Inhibiting Fibrosis. [PDF]

Adv Sci (Weinh)
Li Z, Cao Z, Zhou R, Cheng X, Hu X, Xu S, Dou Z, Du L, Ju D.   +8 more
europepmc   +1 more source

From respiratory infections to environmental exposures: CC16 is a key modulator of airway homeostasis. [PDF]

Front Med (Lausanne)
Berthiaume Fox KA, Li J, Hellinger RD, Ledford JG.   +3 more
europepmc   +1 more source

Downregulation of CXCL16/ADAM10 axis by Simvastatin attenuates tacrolimus-induced tubulointerstitial fibrosis. [PDF]

Sci Rep
Alelowi AA, Alradhi A, Alhowail AH, Aldubayan MA, Abdel-Bakky MS.   +4 more
europepmc   +1 more source

Fibrinogen-like protein 1 induces the formation of an immunosuppressive microenvironment by upregulating fibronectin 1 to promote immune evasion in bladder cancer. [PDF]

Cytojournal
Hu K, Luo L, Li P, Wang X, Sun L.
europepmc   +1 more source